Wenhai Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wenhai Zhao has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
Changwei Zhao
Affiliated Hospital of Changchun University of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, People’s Republic of China
5 shared publicationsYanpeng Wang
Department of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130117, China
3 shared publicationsYinzhen Zhang
Department of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130117, China
3 shared publicationsBinghua Zhang
College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, People’s Republic of China
2 shared publications- Changwei Zhao
Changchun University of Chinese Medicine
2 shared publications Lang Liu
College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, People’s Republic of China
2 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 14, 1932171
Biomechanics of knee osteoarthritis from local knee loading to whole kinetic chain imbalance: a narrative review
The onset and progression of knee osteoarthritis (KOA) are closely associated with abnormal mechanical loading. Previous research has focused largely on local biomechanical factors, such as lower-limb alignment and the knee adduction moment; however, these factors alone may not fully explain the discordance between radiographic degeneration and clinical manifestations such as pain and functional impairment. From a whole-kinetic-chain perspective, the knee functions as an intermediate link within the continuous spine-to-foot chain. Multisegmental malalignment involving the lumbar spine, pelvis, hip, and ankle-foot complex may shift the center of mass and alter the transmission of ground reaction forces, potentially interacting bidirectionally with local knee malalignment to redistribute joint loads and contribute to cartilage damage and pain. By examining the limitations of knee-centered biomechanical studies, we aim to synthesize evidence on the relationship between global alignment and KOA, explores how global-local load interactions may contribute to KOA progression, and proposes a conceptual framework in which the interplay between global and local malalignment may amplify mechano-inflammation and thereby promote disease progression. This review aims to provide new insights into biomechanical phenotyping, progression-risk assessment, and individualized mechanical interventions for KOA.
- 1 October 2026
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 14, 1932171
Open AccessBiomechanics of knee osteoarthritis from local knee loading to whole kinetic chain imbalance: a narrative review
The onset and progression of knee osteoarthritis (KOA) are closely associated with abnormal mechanical loading. Previous research has focused largely on local biomechanical factors, such as lower-limb alignment and the knee adduction moment; however, these factors alone may not fully explain the discordance between radiographic degeneration and clinical manifestations such as pain and functional impairment. From a whole-kinetic-chain perspective, the knee functions as an intermediate link within the continuous spine-to-foot chain. Multisegmental malalignment involving the lumbar spine, pelvis, hip, and ankle-foot complex may shift the center of mass and alter the transmission of ground reaction forces, potentially interacting bidirectionally with local knee malalignment to redistribute joint loads and contribute to cartilage damage and pain. By examining the limitations of knee-centered biomechanical studies, we aim to synthesize evidence on the relationship between global alignment and KOA, explores how global-local load interactions may contribute to KOA progression, and proposes a conceptual framework in which the interplay between global and local malalignment may amplify mechano-inflammation and thereby promote disease progression. This review aims to provide new insights into biomechanical phenotyping, progression-risk assessment, and individualized mechanical interventions for KOA.
- Open Access
- 24 September 2026
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 14, 1937199
Artificial intelligence in the biomechanics of knee osteoarthritis: biomechanical phenotyping, risk stratification, diagnosis, treatment and clinical translation—a narrative review
Structural degeneration, pain and functional limitation in knee osteoarthritis (KOA) often diverge, which suggests that radiographic grading alone cannot explain the heterogeneous clinical course of the disease. Lower-limb alignment, gait strategy, muscle function, joint contact forces and real-world activity exposure jointly shape KOA onset, progression and treatment response. Artificial intelligence (AI) methods provide tools for integrating multimodal imaging, gait, wearable-sensor and clinical data, and can be combined with finite element analysis (FEA) and other computational biomechanical models. Conceptually, we propose an evidence-to-action framework that distinguishes AI-supported measurement, longitudinal prediction and intervention or decision utility, while separating AI-native methods from non-AI digital and computational biomechanical technologies. This structured narrative review synthesizes and critically interprets evidence on artificial intelligence in knee osteoarthritis from a biomechanical perspective, with an emphasis on biomechanical phenotyping across imaging, gait, wearable-sensor and clinical data, together with longitudinal risk stratification, diagnosis, progression prediction, rehabilitation feedback, perioperative management and clinical translation. Available studies indicate that artificial intelligence can support cartilage and meniscus segmentation, imaging-based grading, biomechanical load estimation, preoperative planning, and rehabilitation monitoring, although the strength and clinical maturity of the evidence vary substantially across these applications. Multimodal AI models have identified imaging, biomechanical, sensor-derived, and clinical features associated with structural progression, pain, and functional outcomes, but these associations should not be interpreted as causal or clinically actionable without longitudinal, external, and prospective validation. However, limited external validation, heterogeneous data acquisition, label bias, limited causal interpretability, limited use of patient-centered outcomes and poor workflow integration continue to constrain clinical use. Future AI-enabled KOA assessment should be grounded in biomechanical mechanisms and oriented toward patient outcomes and actionable clinical decisions. Translation will require standardized multimodal data, prospective validation and real-world utility evaluation.
- 24 September 2026
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 14, 1937199
Open AccessArtificial intelligence in the biomechanics of knee osteoarthritis: biomechanical phenotyping, risk stratification, diagnosis, treatment and clinical translation—a narrative review
Structural degeneration, pain and functional limitation in knee osteoarthritis (KOA) often diverge, which suggests that radiographic grading alone cannot explain the heterogeneous clinical course of the disease. Lower-limb alignment, gait strategy, muscle function, joint contact forces and real-world activity exposure jointly shape KOA onset, progression and treatment response. Artificial intelligence (AI) methods provide tools for integrating multimodal imaging, gait, wearable-sensor and clinical data, and can be combined with finite element analysis (FEA) and other computational biomechanical models. Conceptually, we propose an evidence-to-action framework that distinguishes AI-supported measurement, longitudinal prediction and intervention or decision utility, while separating AI-native methods from non-AI digital and computational biomechanical technologies. This structured narrative review synthesizes and critically interprets evidence on artificial intelligence in knee osteoarthritis from a biomechanical perspective, with an emphasis on biomechanical phenotyping across imaging, gait, wearable-sensor and clinical data, together with longitudinal risk stratification, diagnosis, progression prediction, rehabilitation feedback, perioperative management and clinical translation. Available studies indicate that artificial intelligence can support cartilage and meniscus segmentation, imaging-based grading, biomechanical load estimation, preoperative planning, and rehabilitation monitoring, although the strength and clinical maturity of the evidence vary substantially across these applications. Multimodal AI models have identified imaging, biomechanical, sensor-derived, and clinical features associated with structural progression, pain, and functional outcomes, but these associations should not be interpreted as causal or clinically actionable without longitudinal, external, and prospective validation. However, limited external validation, heterogeneous data acquisition, label bias, limited causal interpretability, limited use of patient-centered outcomes and poor workflow integration continue to constrain clinical use. Future AI-enabled KOA assessment should be grounded in biomechanical mechanisms and oriented toward patient outcomes and actionable clinical decisions. Translation will require standardized multimodal data, prospective validation and real-world utility evaluation.
- Open Access
- 4 February 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (4) , 10810-10811
Commentary on “Health-related quality-of-life, complications, and mortality rates after geriatric acetabular fracture”
- 4 February 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (4) , 10810-10811
Open AccessCommentary on “Health-related quality-of-life, complications, and mortality rates after geriatric acetabular fracture”
- Open Access
- 1 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (31) , e43461
Revealing the causal relationship between cathepsin and inflammatory disease of wrist through Mendelian randomization
Although observational studies have suggested associations between cathepsins and inflammatory wrist diseases, critical controversies persist regarding the causality, directionality, and disease-specific mechanisms of these relationships. Conventional clinical studies are unable to determine whether cathepsin-disease associations reflect true causality or spurious links driven by confounding factors or reverse causation. Moreover, systematic causal analyses focusing on protease-mediated mechanisms in wrist-specific inflammatory pathologies remain notably absent. To address these gaps, this study employs bidirectional 2-sample Mendelian randomization (MR) to investigate the causal effects of cathepsins on inflammatory wrist diseases and elucidate their disease-specific roles, thereby providing genetic evidence for targeted therapeutic strategies. We performed bidirectional 2-sample MR using public genome-wide association study summary statistics to assess causal relationships between 10 cathepsins and 4 inflammatory wrist diseases. Instrumental variables (single nucleotide polymorphisms) were selected at genome-wide significance (P < 5 × 10⁻⁶, and r² < 0.001) for exposure-outcome associations. Causality was evaluated via inverse-variance weighted, MR-Egger, and Weighted Median methods. Sensitivity analyses included Cochran Q, MR-Pleiotropy Residual Sum and Outlier, MR-Egger and leave-one-out validation. Univariate MR analysis demonstrated a causal association between genetically determined levels of cathepsin S and the development of carpal tunnel syndrome (odds ratio [OR], 0.954 [95% CI, 0.925–0.984]; P = .003), wrist synovitis (OR, 0.708 [95% CI, 0.529–0.949]; P = .021), and rheumatoid arthritis (RA; OR, 1.048 [95% CI, 1.005–1.092]; P = .029). Similarly, a causal link was established between cathepsin L and RA (OR, 0.948 [95% CI, 0.906–0.991]; P = .019), and between cathepsin F and De Quervain tenosynovitis (OR, 1.213 [95% CI, 1.003–1.466]; P = .046). A reverse MR analysis suggested a causal relationship between cathepsin O and wrist synovitis (OR, 1.047 [95% CI, 1.003–1.093]; P = .038). No causal associations were found for other cathepsins with the diseases studied. The reliability of these findings was confirmed through various robustness tests. Genetic evidence confirms cathepsin S protects against carpal tunnel syndrome and wrist synovitis but increases RA risk. Cathepsin F is positively associated with De Quervain tenosynovitis. Conversely, wrist synovitis elevates cathepsin O levels through reverse causation. These findings validate pathogenic mechanisms of wrist inflammatory disorders and suggest targeted inhibition of specific cathepsins as a promising therapeutic strategy.
- 1 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (31) , e43461
Open AccessRevealing the causal relationship between cathepsin and inflammatory disease of wrist through Mendelian randomization
Although observational studies have suggested associations between cathepsins and inflammatory wrist diseases, critical controversies persist regarding the causality, directionality, and disease-specific mechanisms of these relationships. Conventional clinical studies are unable to determine whether cathepsin-disease associations reflect true causality or spurious links driven by confounding factors or reverse causation. Moreover, systematic causal analyses focusing on protease-mediated mechanisms in wrist-specific inflammatory pathologies remain notably absent. To address these gaps, this study employs bidirectional 2-sample Mendelian randomization (MR) to investigate the causal effects of cathepsins on inflammatory wrist diseases and elucidate their disease-specific roles, thereby providing genetic evidence for targeted therapeutic strategies. We performed bidirectional 2-sample MR using public genome-wide association study summary statistics to assess causal relationships between 10 cathepsins and 4 inflammatory wrist diseases. Instrumental variables (single nucleotide polymorphisms) were selected at genome-wide significance (P < 5 × 10⁻⁶, and r² < 0.001) for exposure-outcome associations. Causality was evaluated via inverse-variance weighted, MR-Egger, and Weighted Median methods. Sensitivity analyses included Cochran Q, MR-Pleiotropy Residual Sum and Outlier, MR-Egger and leave-one-out validation. Univariate MR analysis demonstrated a causal association between genetically determined levels of cathepsin S and the development of carpal tunnel syndrome (odds ratio [OR], 0.954 [95% CI, 0.925–0.984]; P = .003), wrist synovitis (OR, 0.708 [95% CI, 0.529–0.949]; P = .021), and rheumatoid arthritis (RA; OR, 1.048 [95% CI, 1.005–1.092]; P = .029). Similarly, a causal link was established between cathepsin L and RA (OR, 0.948 [95% CI, 0.906–0.991]; P = .019), and between cathepsin F and De Quervain tenosynovitis (OR, 1.213 [95% CI, 1.003–1.466]; P = .046). A reverse MR analysis suggested a causal relationship between cathepsin O and wrist synovitis (OR, 1.047 [95% CI, 1.003–1.093]; P = .038). No causal associations were found for other cathepsins with the diseases studied. The reliability of these findings was confirmed through various robustness tests. Genetic evidence confirms cathepsin S protects against carpal tunnel syndrome and wrist synovitis but increases RA risk. Cathepsin F is positively associated with De Quervain tenosynovitis. Conversely, wrist synovitis elevates cathepsin O levels through reverse causation. These findings validate pathogenic mechanisms of wrist inflammatory disorders and suggest targeted inhibition of specific cathepsins as a promising therapeutic strategy.
- Open Access
- 1 May 2024
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 18, 1583-1602
Integrated Network Pharmacology and Experimental Validation Approach to Investigate the Mechanisms of Radix Rehmanniae Praeparata - Angelica Sinensis - Radix Achyranthis Bidentatae in Treating Knee Osteoarthritis
Background: Knee osteoarthritis (KOA) is a persistent degenerative condition characterized by the deterioration of cartilage. The Chinese herbal formula Radix Rehmanniae Praeparata- Angelica Sinensis-Radix Achyranthis Bidentatae (RAR) has often been used in effective prescriptions for KOA as the main functional drug, but its underlying mechanism remains unclear. Therefore, network pharmacology and verification experiments were employed to investigate the impact and mode of action of RAR in the treatment of KOA. Methods: The destabilization of the medial meniscus model (DMM) was utilized to assess the anti-KOA effect of RAR by using gait analysis, micro-computed tomography (Micro-CT), and histology. Primary chondrocytes were extracted from the rib cartilage of a newborn mouse. The protective effects of RAR on OA cells were evaluated using a CCK‐8 assay. The antioxidative effect of RAR was determined by measuring reactive oxygen species (ROS), superoxide dismutase (SOD), and glutathione (GSH) production. Furthermore, network pharmacology and molecular docking were utilized to propose possible RAR targets for KOA, which were further verified through experiments. Results: In vivo, RAR significantly ameliorated DMM-induced KOA characteristics, such as subchondral bone sclerosis, cartilage deterioration, gait abnormalities, and the degree of knee swelling. In vitro, RAR stimulated chondrocyte proliferation and the expression of Col2a1, Comp, and Acan. Moreover, RAR treatment significantly reduced ROS accumulation in an OA cell model induced by IL-1β and increased the activity of antioxidant enzymes (SOD and GSH). Network pharmacology analysis combined with molecular docking showed that Mapk1 might be a key therapeutic target. Subsequent research showed that RAR could downregulate Mapk1 mRNA levels in IL-1β-induced chondrocytes and DMM-induced rats. Conclusion: RAR inhibited extracellular matrix (ECM) degradation and oxidative stress response via the MAPK signaling pathway in KOA, and Mapk1 may be a core target.
- 1 May 2024
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 18, 1583-1602
Open AccessIntegrated Network Pharmacology and Experimental Validation Approach to Investigate the Mechanisms of Radix Rehmanniae Praeparata - Angelica Sinensis - Radix Achyranthis Bidentatae in Treating Knee Osteoarthritis
Background: Knee osteoarthritis (KOA) is a persistent degenerative condition characterized by the deterioration of cartilage. The Chinese herbal formula Radix Rehmanniae Praeparata- Angelica Sinensis-Radix Achyranthis Bidentatae (RAR) has often been used in effective prescriptions for KOA as the main functional drug, but its underlying mechanism remains unclear. Therefore, network pharmacology and verification experiments were employed to investigate the impact and mode of action of RAR in the treatment of KOA. Methods: The destabilization of the medial meniscus model (DMM) was utilized to assess the anti-KOA effect of RAR by using gait analysis, micro-computed tomography (Micro-CT), and histology. Primary chondrocytes were extracted from the rib cartilage of a newborn mouse. The protective effects of RAR on OA cells were evaluated using a CCK‐8 assay. The antioxidative effect of RAR was determined by measuring reactive oxygen species (ROS), superoxide dismutase (SOD), and glutathione (GSH) production. Furthermore, network pharmacology and molecular docking were utilized to propose possible RAR targets for KOA, which were further verified through experiments. Results: In vivo, RAR significantly ameliorated DMM-induced KOA characteristics, such as subchondral bone sclerosis, cartilage deterioration, gait abnormalities, and the degree of knee swelling. In vitro, RAR stimulated chondrocyte proliferation and the expression of Col2a1, Comp, and Acan. Moreover, RAR treatment significantly reduced ROS accumulation in an OA cell model induced by IL-1β and increased the activity of antioxidant enzymes (SOD and GSH). Network pharmacology analysis combined with molecular docking showed that Mapk1 might be a key therapeutic target. Subsequent research showed that RAR could downregulate Mapk1 mRNA levels in IL-1β-induced chondrocytes and DMM-induced rats. Conclusion: RAR inhibited extracellular matrix (ECM) degradation and oxidative stress response via the MAPK signaling pathway in KOA, and Mapk1 may be a core target.
- Open Access
- 5 January 2024
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1324449
Visceral adipose tissue and osteoarthritis, a two-sample Mendelian randomized study
Background: The relationship between visceral adipose tissue and osteoarthritis is not clear. The purpose of our study was to explore the relationship between visceral adipose tissue and osteoarthritis.Methods: We used a two-sample Mendelian randomization method to select single-nucleotide polymorphisms (SNPs) significantly associated with visceral adipose tissue as instrumental variables to explore the relationship between visceral adipose tissue and all osteoarthritis, hand osteoarthritis, hip osteoarthritis, knee osteoarthritis, and spine osteoarthritis. The reliability of the results was tested using sensitivity analysis.Results: Our findings indicated that visceral adipose tissue was associated with all osteoarthritis, hip osteoarthritis, knee osteoarthritis, and spine osteoarthritis (all osteoarthritis: OR = 1.399, 95% CI: 1.335–1.467, p = 7.95e-44; hip osteoarthritis: OR = 1.399, 95% CI: 1.284–1.524, p = 1.41e-14; knee osteoarthritis: OR = 1.794, 95% CI: 1.662–1.937, p = 1.33e-50; and spine osteoarthritis: OR = 1.445, 95% CI: 1.314–1.589, p = 2.89e-14). Sensitivity analysis demonstrated the reliability of these results.Conclusion: Our study suggests that genetically predicted visceral adipose tissue is associated with osteoarthritis. Reducing the accumulation of visceral adipose tissue could potentially have an impact on the incidence of osteoarthritis.
- 5 January 2024
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1324449
Open AccessVisceral adipose tissue and osteoarthritis, a two-sample Mendelian randomized study
Background: The relationship between visceral adipose tissue and osteoarthritis is not clear. The purpose of our study was to explore the relationship between visceral adipose tissue and osteoarthritis.Methods: We used a two-sample Mendelian randomization method to select single-nucleotide polymorphisms (SNPs) significantly associated with visceral adipose tissue as instrumental variables to explore the relationship between visceral adipose tissue and all osteoarthritis, hand osteoarthritis, hip osteoarthritis, knee osteoarthritis, and spine osteoarthritis. The reliability of the results was tested using sensitivity analysis.Results: Our findings indicated that visceral adipose tissue was associated with all osteoarthritis, hip osteoarthritis, knee osteoarthritis, and spine osteoarthritis (all osteoarthritis: OR = 1.399, 95% CI: 1.335–1.467, p = 7.95e-44; hip osteoarthritis: OR = 1.399, 95% CI: 1.284–1.524, p = 1.41e-14; knee osteoarthritis: OR = 1.794, 95% CI: 1.662–1.937, p = 1.33e-50; and spine osteoarthritis: OR = 1.445, 95% CI: 1.314–1.589, p = 2.89e-14). Sensitivity analysis demonstrated the reliability of these results.Conclusion: Our study suggests that genetically predicted visceral adipose tissue is associated with osteoarthritis. Reducing the accumulation of visceral adipose tissue could potentially have an impact on the incidence of osteoarthritis.
- Open Access
- 14 October 2023
- Published by Knowledge E DMCC in Iranian Journal of Public Health
- Vol. 52 (10) , 2099-2108
Physical Activity, Sedentary Behavior, and Osteoarthritis: A Two-Sample Mendelian Randomization Analysis
Background: Sedentary behavior and physical activity are still ambiguous in their effects on osteoarthritis. We aimed to evaluate the effects of physical activity and sedentary behavior on osteoarthritis to provide a reference for the prevention of osteoarthritis. Methods: This study was conducted in Changchun, China in 2022. We used two-sample Mendelian randomization with the SNP as an instrumental variable to investigate the effect of physical activity and sedentary behavior on osteoarthritis. In addition, a two-step Mendelian randomization method was used to test whether mediating factors (BMI, smoking, Apolipoprotein B) were involved in mediating the effects of exposure factors on osteoarthritis. Results: TV watching was causally related to knee osteoarthritis and spine osteoarthritis, and they were positively correlated (knee osteoarthritis: OR=1.162,95 %CI: 1.027-1.315, P=0.017; spine osteoarthritis: OR=1.208,95 %CI: 1.033-1.413, P=0.018). BMI played a mediating role in the process of TV watching with knee osteoarthritis and spine osteoarthritis. ((The proportion of BMI mediating effect: knee osteoarthritis: 47.1% (95% CI: 36.7%~63.2%); spine osteoarthritis: 29.5% (95% CI: 19.3%~40.8%)). The proportion of Smoking mediating effect in the process of TV watching with spine osteoarthritis was 16.1% (95% CI: 3.7% ~ 31.6%). Conclusion: TV watching is a potential risk factor for osteoarthritis and plays a role through modifiable factors such as BMI and smoking, therefore, interventions on these factors have the potential to reduce the burden of osteoarthritis caused by longer TV watching times.
- 14 October 2023
- Published by Knowledge E DMCC in Iranian Journal of Public Health
- Vol. 52 (10) , 2099-2108
Open AccessPhysical Activity, Sedentary Behavior, and Osteoarthritis: A Two-Sample Mendelian Randomization Analysis
Background: Sedentary behavior and physical activity are still ambiguous in their effects on osteoarthritis. We aimed to evaluate the effects of physical activity and sedentary behavior on osteoarthritis to provide a reference for the prevention of osteoarthritis. Methods: This study was conducted in Changchun, China in 2022. We used two-sample Mendelian randomization with the SNP as an instrumental variable to investigate the effect of physical activity and sedentary behavior on osteoarthritis. In addition, a two-step Mendelian randomization method was used to test whether mediating factors (BMI, smoking, Apolipoprotein B) were involved in mediating the effects of exposure factors on osteoarthritis. Results: TV watching was causally related to knee osteoarthritis and spine osteoarthritis, and they were positively correlated (knee osteoarthritis: OR=1.162,95 %CI: 1.027-1.315, P=0.017; spine osteoarthritis: OR=1.208,95 %CI: 1.033-1.413, P=0.018). BMI played a mediating role in the process of TV watching with knee osteoarthritis and spine osteoarthritis. ((The proportion of BMI mediating effect: knee osteoarthritis: 47.1% (95% CI: 36.7%~63.2%); spine osteoarthritis: 29.5% (95% CI: 19.3%~40.8%)). The proportion of Smoking mediating effect in the process of TV watching with spine osteoarthritis was 16.1% (95% CI: 3.7% ~ 31.6%). Conclusion: TV watching is a potential risk factor for osteoarthritis and plays a role through modifiable factors such as BMI and smoking, therefore, interventions on these factors have the potential to reduce the burden of osteoarthritis caused by longer TV watching times.
- Open Access
- 12 October 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1243867
No evidence of a causal relationship between ankylosing spondylitis and cardiovascular disease: a two-sample Mendelian randomization study
Objective: Observational studies have suggested an increased risk of cardiovascular disease in individuals with ankylosing spondylitis. However, these studies are prone to confounding factors and reverse causality. To address these limitations, we conducted a Mendelian randomization study to assess the causal relationship between AS and CVD.Methods: The study population comprises 9,069 individuals with ankylosing spondylitis and 509,093 individuals with either of six common cardiovascular diseases and a related indicator. Causal analysis using summary effect estimates and inverse variance weighting were employed as the main methods.Results: The CAUSE analysis showed no evidence of a causal relationship between AS and CVD. The odds ratios for total CVD, heart failure, myocardial infarction, valvular heart disease, ischemic heart disease, and venous thromboembolism, Arterial stiffness index, were as follows: OR, 1.01; 95% confidence interval, 0.96–1.05; P = 0.91; OR, 1.03; 95% CI, 0.99–1.08; P = 0.50; OR, 0.94; 95% CI, 0.86–1.03; P = 0.53; OR, 0.99; 95% CI, 0.94–1.04; P = 0.99; OR, 0.98; 95% CI, 0.91–1.04; P = 0.94; OR, 0.98; 95% CI, 0.91–1.04; P = 0.99; β, −0.0019; 95% CI, 0.97–1.01; P = 0.99. The IVW and weighted median methods also yielded consistent results, and no heterogeneity or pleiotropy was found. Likewise, a reverse Mendelian randomization analysis did not uncover a heritable causal relationship between AS and CVD.Conclusion: This Mendelian randomization study does not support a causal relationship between AS and CVD. Further research is needed to confirm this association.
- 12 October 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1243867
Open AccessNo evidence of a causal relationship between ankylosing spondylitis and cardiovascular disease: a two-sample Mendelian randomization study
Objective: Observational studies have suggested an increased risk of cardiovascular disease in individuals with ankylosing spondylitis. However, these studies are prone to confounding factors and reverse causality. To address these limitations, we conducted a Mendelian randomization study to assess the causal relationship between AS and CVD.Methods: The study population comprises 9,069 individuals with ankylosing spondylitis and 509,093 individuals with either of six common cardiovascular diseases and a related indicator. Causal analysis using summary effect estimates and inverse variance weighting were employed as the main methods.Results: The CAUSE analysis showed no evidence of a causal relationship between AS and CVD. The odds ratios for total CVD, heart failure, myocardial infarction, valvular heart disease, ischemic heart disease, and venous thromboembolism, Arterial stiffness index, were as follows: OR, 1.01; 95% confidence interval, 0.96–1.05; P = 0.91; OR, 1.03; 95% CI, 0.99–1.08; P = 0.50; OR, 0.94; 95% CI, 0.86–1.03; P = 0.53; OR, 0.99; 95% CI, 0.94–1.04; P = 0.99; OR, 0.98; 95% CI, 0.91–1.04; P = 0.94; OR, 0.98; 95% CI, 0.91–1.04; P = 0.99; β, −0.0019; 95% CI, 0.97–1.01; P = 0.99. The IVW and weighted median methods also yielded consistent results, and no heterogeneity or pleiotropy was found. Likewise, a reverse Mendelian randomization analysis did not uncover a heritable causal relationship between AS and CVD.Conclusion: This Mendelian randomization study does not support a causal relationship between AS and CVD. Further research is needed to confirm this association.
- Open Access
- 21 August 2023
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 35 (11) , 2437-2444
Effects of blood pressure and antihypertensive drugs on osteoarthritis: a mendelian randomized study
Background: Previous studies have suggested that antihypertensive drugs may play a role in the treatment of osteoarthritis, but these studies may be limited by confounding factors and lead to biased results. Therefore, we conducted a Mendelian randomization study to investigate the effects of blood pressure and antihypertensive drugs on osteoarthritis. Methods: We used published large-scale genome-wide association data and applied univariate and multivariate Mendelian randomization methods. The main analysis model was inverse variance weighting, and the reliability of the results was tested using MR-Egger intercept analysis, Cochran's Q test, and leave-one-out analysis. We comprehensively evaluated the relationship between systolic blood pressure, diastolic blood pressure, 12 antihypertensive drugs, and osteoarthritis. We also conducted verification in the independent queue of UK Biobank and built a simple linear regression model to obtain an independent comparison. Results: We found no evidence that systolic and diastolic blood pressure significantly affected osteoarthritis. However, among antihypertensive drugs, we observed a significant positive correlation between potassium-preserving diuretics and aldosterone antagonists and all osteoarthritis (OR: 0.560, 95% CI 0.406–0.772, P = 0.0004). Sensitivity analysis showed no horizontal pleiotropy or heterogeneity, and the leave-one-out analysis demonstrated the reliability of the results. This result was replicated with nominally statistical significance in the validation cohort and exhibited significant correlation in the linear regression analysis. Conclusions: Our study suggested that controlling the protein targets of potassium-sparing diuretics and aldosterone antagonists may have beneficial results for osteoarthritis. These findings provide valuable medication strategies for the control of hypertension in patients with osteoarthritis.
- 21 August 2023
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 35 (11) , 2437-2444
Open AccessEffects of blood pressure and antihypertensive drugs on osteoarthritis: a mendelian randomized study
Background: Previous studies have suggested that antihypertensive drugs may play a role in the treatment of osteoarthritis, but these studies may be limited by confounding factors and lead to biased results. Therefore, we conducted a Mendelian randomization study to investigate the effects of blood pressure and antihypertensive drugs on osteoarthritis. Methods: We used published large-scale genome-wide association data and applied univariate and multivariate Mendelian randomization methods. The main analysis model was inverse variance weighting, and the reliability of the results was tested using MR-Egger intercept analysis, Cochran's Q test, and leave-one-out analysis. We comprehensively evaluated the relationship between systolic blood pressure, diastolic blood pressure, 12 antihypertensive drugs, and osteoarthritis. We also conducted verification in the independent queue of UK Biobank and built a simple linear regression model to obtain an independent comparison. Results: We found no evidence that systolic and diastolic blood pressure significantly affected osteoarthritis. However, among antihypertensive drugs, we observed a significant positive correlation between potassium-preserving diuretics and aldosterone antagonists and all osteoarthritis (OR: 0.560, 95% CI 0.406–0.772, P = 0.0004). Sensitivity analysis showed no horizontal pleiotropy or heterogeneity, and the leave-one-out analysis demonstrated the reliability of the results. This result was replicated with nominally statistical significance in the validation cohort and exhibited significant correlation in the linear regression analysis. Conclusions: Our study suggested that controlling the protein targets of potassium-sparing diuretics and aldosterone antagonists may have beneficial results for osteoarthritis. These findings provide valuable medication strategies for the control of hypertension in patients with osteoarthritis.
- Open Access
- 16 December 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (50) , e32132
Analyzing network pharmacology and molecular docking to clarify Duhuo Jisheng decoction potential mechanism of osteoarthritis mitigation
As a classic remedy for treating Osteoarthritis (OA), Duhuo Jisheng decoction has successfully treated countless patients. Nevertheless, its specific mechanism is unknown. This study explored the active constituents of Duhuo Jisheng decoction and the potential molecular mechanisms for treating OA using a Network Pharmacology approaches. Screening active components and corresponding targets of Duhuo parasite decoction by traditional Chinese medicine systems pharmacology database and analysis platform database. Combining the following databases yielded OA disease targets: GeneCards, DrugBank, PharmGkb, Online Mendelian Inheritance in Man, and therapeutic target database. The interaction analysis of the herb-active ingredient-core target network and protein–protein interaction protein network was constructed by STRING platform and Cytoscape software. Gene ontology functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were carried out. PyMOL and other software were used to verify the molecular docking between the essential active components and the core target. 262 active ingredients were screened, and their main components were quercetin, kaempferol, wogonin, baicalein, and beta-carotene. 108 intersection targets of disease and drug were identified, and their main components were RELA, FOS, STAT3, MAPK14, MAPK1, JUN, and ESR1. Gene ontology analysis showed that the key targets were mainly involved in biological processes such as response to lipopolysaccharide, response to xenobiotic stimulus, and response to nutrient levels. The results of Kyoto Encyclopedia of Genes and Genomes analysis show that the signal pathways include the AGE − RAGE signaling pathway, IL − 17 signaling pathway, TNF signaling pathway, and Toll − like receptor signaling pathway. Molecular docking showed that the main active components of Duhuo parasitic decoction had a good bonding activity with the key targets in treating OA. Duhuo Jisheng decoction can reduce the immune-inflammatory reaction, inhibit apoptosis of chondrocytes, strengthen proliferation and repair of chondrocytes and reduce the inflammatory response in a multi-component-multi-target-multi-pathway way to play a role in the treatment of OA.
- 16 December 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (50) , e32132
Open AccessAnalyzing network pharmacology and molecular docking to clarify Duhuo Jisheng decoction potential mechanism of osteoarthritis mitigation
As a classic remedy for treating Osteoarthritis (OA), Duhuo Jisheng decoction has successfully treated countless patients. Nevertheless, its specific mechanism is unknown. This study explored the active constituents of Duhuo Jisheng decoction and the potential molecular mechanisms for treating OA using a Network Pharmacology approaches. Screening active components and corresponding targets of Duhuo parasite decoction by traditional Chinese medicine systems pharmacology database and analysis platform database. Combining the following databases yielded OA disease targets: GeneCards, DrugBank, PharmGkb, Online Mendelian Inheritance in Man, and therapeutic target database. The interaction analysis of the herb-active ingredient-core target network and protein–protein interaction protein network was constructed by STRING platform and Cytoscape software. Gene ontology functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were carried out. PyMOL and other software were used to verify the molecular docking between the essential active components and the core target. 262 active ingredients were screened, and their main components were quercetin, kaempferol, wogonin, baicalein, and beta-carotene. 108 intersection targets of disease and drug were identified, and their main components were RELA, FOS, STAT3, MAPK14, MAPK1, JUN, and ESR1. Gene ontology analysis showed that the key targets were mainly involved in biological processes such as response to lipopolysaccharide, response to xenobiotic stimulus, and response to nutrient levels. The results of Kyoto Encyclopedia of Genes and Genomes analysis show that the signal pathways include the AGE − RAGE signaling pathway, IL − 17 signaling pathway, TNF signaling pathway, and Toll − like receptor signaling pathway. Molecular docking showed that the main active components of Duhuo parasitic decoction had a good bonding activity with the key targets in treating OA. Duhuo Jisheng decoction can reduce the immune-inflammatory reaction, inhibit apoptosis of chondrocytes, strengthen proliferation and repair of chondrocytes and reduce the inflammatory response in a multi-component-multi-target-multi-pathway way to play a role in the treatment of OA.